Fear of COVID-19: reflections on disease severity, sleep and anxiety in fibromyalgia patients

Year 2022, Volume: 5 Issue: 3, 887 - 892, 30.05.2022

Betül Çiftçi , Deniz Öke

https://doi.org/10.32322/jhsm.1089198

Abstract

Aim: This study aimed to assess the effects of COVID- 19 fear and anxiety on disease severity, pain, sleep quality and health-related quality of life in fibromyalgia patients.
Material and Method: Sixty-four patients with diagnosis fibromyalgia and sixty-five healthy volunteers over 18 years of age were enrolled in the study. Sociodemographic features were evaluated. Fibromyalgia Impact Questionnaire (FIQ), Short Form 36 (SF-36), Coronavirus Anxiety Scale (CAS), Obsession with COVID-19 Scale(OCS), and Pittsburgh Sleep Quality Index (PSQI) were administered to all participants.
Results: The mean values of CAS, FIQ, PSQI, and BDI were found to be higher in the fibromyalgia group than the control group (p<0.05). The median/mean value of CAS, OCS, and BDI were higher in patients with losing a first-degree relative patient due to COVID-19 in fibromyalgia group, these results were statistically significant (p<0.05).
Conclusion: According to the results of this study, fibromyalgia may be affected more by psychological stress which affects disease severity during COVID 19 pandemic.

Keywords

fibromyalgia, COVID-19, anxiety

References

• Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020; 395: 689–97.
• Available from: https: //www.who.int/news/item/27-04-2020-who-timeline---covid-19
• Gemcioğlu E, Başer S, İnan O, et al. Effects of blood group types on risk of infection, disease severity, and mortality in COVID-19 patients. J Health Sci Med 2022; 5: 374-78.
• Kara U, Şimşek F, Özhan MÖ, et al. The factor analysis approach to mortality prediction in COVID-19 severe disease using laboratory values: a retrospective study. J Health Sci Med 2022; 5: 528-33.
• Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol.2020; 16: 645–60.
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4: 561-71.
• Hıslı, N. Beck Depresyon envanterinin gecerliligi uzerine bir calisma. Psikoloji Derg 1988 ; 6: 118–22.
• Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193–213.
• Agargun MY, Kara H AO. The validity and reliability of the Pittsburgh sleep quality index. Turk Psikiyatr Derg 1996; 7: 107–15.
• Kocyigit H, Aydemir O, Olmez N MA. Reliability and validity of the Turkish version of Short-Form-36 (SF-36). Turkish J Drugs Ther 1999; 12: 102–6.
• Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000; 20: 9-12.
• Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Stud 2020; 44: 393-401.
• Evren C, Evren B, Dalbudak E, Topcu M, Kutlu N. Measuring anxiety related to COVID-19: A Turkish validation study of the Coronavirus Anxiety Scale. Death Stud 2020; 3: 1-7 .
• Lee SA. How much "Thinking" about COVID-19 is clinically dysfunctional? Brain Behav Immun 2020 ; 87: 97-8.
• Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Molecul Sci 2021; 22: 3891.
• Bhargava J, Hurley JA. Fibromyalgia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; October 13, 2021.
• Epstein SA, Kay G, Clauw D, et al. Psychiatric disorders in patients with fibromyalgia: a multicenter investigation. Psychosomatics. 1999; 40: 57–63.
• Leino P, Magni G. Depressive and distress symptoms as predictors of low back pain, neck-shoulder pain, and other musculoskeletal morbidity: a 10-year follow-up of metal industry employees. Pain. 1993; 53: 89–94.
• Tull MT, Edmonds KA, Scamaldo KM, Richmond JR, Rose JP, Gratz KL. Psychological outcomes associated with stay-at-home orders and the perceived impact of COVID-19 on Daily Life. Psychiatry Res 2020; 289: 113098.
• Wilkialis L, Rodrigues NB, Cha DS, et al. Social isolation, loneliness and generalized anxiety: implications and associations during the COVID-19 quarantine. Brain Sci 2021; 11: 1620.
• Giesecke T, Williams DA, Harris RE, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003; 48: 2916-22.
• Batres-Marroquín AB, Medina-García AC, Vargas Guerrero A, Barrera-Villalpando MI, Martínez-Lavín M, Martínez-Martínez LA. Effect of COVID-19 pandemic lockdown on fibromyalgia symptoms. J Clin Rheumatol 2022; 28: 289-91.
• Martinez-Lavin M, Vidal M, Barbosa RE, Pineda C, Casanova JM, Nava A. Norepinephrine-evoked pain in fibromyalgia. A randomized pilot study [ISRCTN70707830]. BMC Musculoskelet Disord 2002; 3: 2.
• Mundal I, Gråwe RW, Bjørngaard JH, Linaker OM, Fors EA. Prevalence and long-term predictors of persistent chronic widespread pain in the general population in an 11-year prospective study: the HUNT study. BMC Musculoskelet Disord 2014; 15: 213.
• Finan PH, Goodin BR, Smith MT. The association of sleep and pain: An update and a path forward. J Pain 2013; 14: 1539–52.
• Donzella SM, Kohler LN, Crane TE, et al. COVID-19 Infection, the COVID-19 pandemic, and changes in sleep. Front Public Health 2022; 9: 795320.
• Dell'Osso L, Carmassi C, Consoli G, et al. Lifetime post-traumatic stress symptoms are related to the health-related quality of life and severity of pain/fatigue in patients with fibromyalgia. Clin Exp Rheumatol 2011; 29: 73-8.
• Beneria A, Castell-Panisello E, Sorribes-Puertas M, et al. End of life intervention program during COVID-19 in Vall d'Hebron University Hospital. Front Psychiatry 2021; 12: 608973.